Peter Wolff, MHA

Trial Coordinator
The National Institute of Allergy and Infectious Diseases
Rockville, MD

Disclosure: Nothing to disclose

Presentation(s):

• LB10 - A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population

  Friday, October 4
  2:05 PM – 2:15 PM